Pharvaris N.V. SEC filings PHVS

Pharvaris N.V. has 327 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form 20-F, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 8, 2026. The company's fiscal year ends on December 31.

Pharvaris N.V. SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Sep 8, 2026 Sep 8, 2026
6-K Current report (foreign issuer) Sep 8, 2026 Sep 8, 2026
6-K Current report (foreign issuer) Aug 12, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Jun 26, 2026 Jun 26, 2026
6-K Current report (foreign issuer) Jun 11, 2026 Jun 11, 2026
6-K Current report (foreign issuer) May 12, 2026 May 12, 2026
6-K Current report (foreign issuer) May 11, 2026 May 11, 2026
424B5 Prospectus supplement May 8, 2026 —
20-F Annual report (foreign issuer) Apr 2, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Apr 2, 2026 Mar 31, 2026
6-K Current report (foreign issuer) Jan 12, 2026 Jan 12, 2026
6-K Current report (foreign issuer) Dec 3, 2025 Dec 3, 2025
6-K Current report (foreign issuer) Nov 12, 2025 Nov 12, 2025
POSASR Filing Sep 23, 2025 —
6-K Current report (foreign issuer) Sep 8, 2025 Sep 8, 2025
6-K Current report (foreign issuer) Aug 12, 2025 Jun 30, 2025
UPLOAD Letter from the SEC Aug 11, 2025 —
CORRESP Letter to the SEC Aug 6, 2025 —
6-K Current report (foreign issuer) Jul 24, 2025 Jul 24, 2025
UPLOAD Letter from the SEC Jul 24, 2025 —
424B5 Prospectus supplement Jul 24, 2025 —
FWP Free writing prospectus Jul 23, 2025 —
424B5 Prospectus supplement Jul 22, 2025 —
6-K Current report (foreign issuer) Jul 10, 2025 Jul 10, 2025
6-K Current report (foreign issuer) Jun 27, 2025 Jun 27, 2025
6-K Current report (foreign issuer) Jun 10, 2025 Jun 10, 2025
6-K Current report (foreign issuer) May 13, 2025 May 13, 2025
6-K Current report (foreign issuer) Apr 7, 2025 Apr 7, 2025
20-F Annual report (foreign issuer) Apr 7, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Jan 13, 2025 Jan 13, 2025
6-K Current report (foreign issuer) Nov 13, 2024 Nov 13, 2024
6-K Current report (foreign issuer) Sep 25, 2024 Sep 25, 2024
6-K Current report (foreign issuer) Sep 23, 2024 Sep 23, 2024
6-K Current report (foreign issuer) Sep 5, 2024 Sep 5, 2024
6-K Current report (foreign issuer) Aug 14, 2024 Jun 30, 2024
6-K Current report (foreign issuer) Jun 28, 2024 Jun 28, 2024
6-K Current report (foreign issuer) Jun 11, 2024 Jun 11, 2024
6-K Current report (foreign issuer) Jun 4, 2024 Jun 4, 2024
6-K Current report (foreign issuer) May 8, 2024 May 8, 2024
F-3ASR Filing Apr 12, 2024 —
20-F Annual report (foreign issuer) Apr 10, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Apr 10, 2024 Apr 10, 2024
F-3ASR Filing Mar 6, 2024 —
6-K Current report (foreign issuer) Mar 6, 2024 Mar 6, 2024
6-K Current report (foreign issuer) Feb 16, 2024 Feb 16, 2024
6-K Current report (foreign issuer) Feb 7, 2024 Feb 7, 2024
6-K Current report (foreign issuer) Jan 22, 2024 Jan 22, 2024
6-K Current report (foreign issuer) Jan 8, 2024 Jan 8, 2024
6-K Current report (foreign issuer) Dec 8, 2023 Dec 8, 2023
424B5 Prospectus supplement Dec 7, 2023 —
FWP Free writing prospectus Dec 6, 2023 —
6-K Current report (foreign issuer) Dec 6, 2023 Dec 6, 2023
6-K Current report (foreign issuer) Nov 2, 2023 Nov 2, 2023
424B5 Prospectus supplement Aug 24, 2023 —
EFFECT Filing Aug 16, 2023 —
CORRESP Letter to the SEC Aug 15, 2023 —
UPLOAD Letter from the SEC Aug 14, 2023 —
F-3 Shelf registration (foreign issuer) Aug 7, 2023 —
6-K Current report (foreign issuer) Aug 7, 2023 Jun 30, 2023
6-K Current report (foreign issuer) Jul 3, 2023 Jul 3, 2023
6-K Current report (foreign issuer) Jun 27, 2023 Jun 27, 2023
6-K Current report (foreign issuer) Jun 26, 2023 Jun 26, 2023
6-K Current report (foreign issuer) Jun 23, 2023 Jun 23, 2023
6-K Current report (foreign issuer) Jun 20, 2023 Jun 20, 2023
6-K Current report (foreign issuer) Jun 1, 2023 Jun 1, 2023
6-K Current report (foreign issuer) May 8, 2023 May 8, 2023
6-K Current report (foreign issuer) Apr 5, 2023 Apr 5, 2023
20-F Annual report (foreign issuer) Apr 5, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Mar 10, 2023 Mar 10, 2023
6-K Current report (foreign issuer) Mar 8, 2023 Mar 8, 2023
6-K Current report (foreign issuer) Feb 14, 2023 Feb 14, 2023
6-K Current report (foreign issuer) Jan 9, 2023 Jan 9, 2023
6-K Current report (foreign issuer) Dec 8, 2022 Dec 8, 2022
6-K Current report (foreign issuer) Dec 8, 2022 Dec 8, 2022
6-K Current report (foreign issuer) Nov 1, 2022 Nov 1, 2022
6-K Current report (foreign issuer) Sep 12, 2022 Jun 30, 2022
6-K Current report (foreign issuer) Aug 22, 2022 Aug 22, 2022
6-K Current report (foreign issuer) Jul 13, 2022 Jul 13, 2022
6-K/A Filing Jul 5, 2022 Jul 1, 2022
6-K Current report (foreign issuer) Jun 29, 2022 Jun 29, 2022
6-K Current report (foreign issuer) Jun 14, 2022 Jun 14, 2022
6-K Current report (foreign issuer) May 11, 2022 May 11, 2022
6-K Current report (foreign issuer) May 11, 2022 May 11, 2022
6-K Current report (foreign issuer) Mar 29, 2022 Mar 29, 2022
20-F Annual report (foreign issuer) Mar 29, 2022 Dec 31, 2021
424B5 Prospectus supplement Mar 15, 2022 —
EFFECT Filing Mar 10, 2022 —
CORRESP Letter to the SEC Mar 8, 2022 —
UPLOAD Letter from the SEC Mar 3, 2022 —
F-3 Shelf registration (foreign issuer) Mar 2, 2022 —
6-K Current report (foreign issuer) Jan 10, 2022 Jan 10, 2022
6-K Current report (foreign issuer) Dec 22, 2021 Dec 22, 2021
6-K Current report (foreign issuer) Dec 7, 2021 Dec 7, 2021
6-K Current report (foreign issuer) Nov 10, 2021 Nov 10, 2021
6-K Current report (foreign issuer) Jul 30, 2021 Jul 30, 2021
6-K Current report (foreign issuer) Jul 1, 2021 Jul 1, 2021
6-K Current report (foreign issuer) Jun 29, 2021 Jun 29, 2021
6-K Current report (foreign issuer) Jun 11, 2021 Jun 11, 2021
6-K Current report (foreign issuer) May 26, 2021 May 26, 2021
6-K Current report (foreign issuer) May 12, 2021 May 12, 2021
6-K/A Filing May 3, 2021 Apr 30, 2021
6-K Current report (foreign issuer) Apr 29, 2021 Apr 29, 2021
20-F Annual report (foreign issuer) Apr 29, 2021 Dec 31, 2020
S-8 Employee stock plan registration Feb 9, 2021 —
424B4 Prospectus Feb 8, 2021 —
EFFECT Filing Feb 4, 2021 —
F-1MEF Filing Feb 4, 2021 —
SEC STAFF LETTER Filing Feb 4, 2021 —
CERT 8a cert Feb 4, 2021 —
8-A12B Filing Feb 4, 2021 —
CORRESP Letter to the SEC Feb 2, 2021 —
CORRESP Letter to the SEC Feb 2, 2021 —
CORRESP Letter to the SEC Feb 1, 2021 —
F-1/A Filing Feb 1, 2021 —
UPLOAD Letter from the SEC Jan 28, 2021 —
CORRESP Letter to the SEC Jan 22, 2021 —
CORRESP Letter to the SEC Jan 22, 2021 —
F-1/A Filing Jan 22, 2021 —
F-1 Registration statement (foreign issuer) Jan 15, 2021 —
UPLOAD Letter from the SEC Jan 15, 2021 —
SEC STAFF LETTER Filing Jan 12, 2021 —
DRS/A Filing Jan 11, 2021 —
DRSLTR Filing Jan 11, 2021 —
UPLOAD Letter from the SEC Jan 4, 2021 —
DRSLTR Filing Dec 18, 2020 —
DRS/A Filing Dec 18, 2020 —
UPLOAD Letter from the SEC Dec 10, 2020 —
DRS Filing Nov 12, 2020 —

Showing 128 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PHVS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Netherlands
Headquarters
Leiden
SEC filer status
Large accelerated filer
SEC CIK
1830487
Former names
Pharvaris, B.V. (until Feb 4, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.